Annual report pursuant to Section 13 and 15(d)

Equity Compensation Plans - Overview of Equity Incentive Plans Narrative (Details)

v3.20.4
Equity Compensation Plans - Overview of Equity Incentive Plans Narrative (Details)
$ in Thousands
12 Months Ended
Aug. 14, 2019
shares
Dec. 31, 2020
USD ($)
plan
shares
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Stock Option Disclosures        
Share-based incentive plans | plan   2    
Share-based compensation expense | $     $ 10,304 $ 7,606
New Axogen Plan        
Stock Option Disclosures        
Shares authorized for issuance (in shares) 3,385,482 1,793,090    
Additional shares authorized for future issuance (in shares) 3,000,000      
Unallocated shares available for issuance (in shares) 385,482      
Prior Axogen Plan        
Stock Option Disclosures        
Unrecognized compensation costs related to non-vested stock options and restricted stock awards | $   $ 16,568    
Prior Axogen Plan | Stock options        
Stock Option Disclosures        
Weighted average period of recognition of unrecognized compensation expense   2 years 1 month 9 days    
Prior Axogen Plan | RSUs        
Stock Option Disclosures        
Weighted average period of recognition of unrecognized compensation expense   2 years 2 months 23 days